With medical aid in dying illegal in Ohio, terminally ill patients face crushing logistical and financial barriers to die on ...

Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and ...

Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.

Phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease, to be presented at ...

For most people, spring and summer means fun in the sun. For this 24-year-old, it means avoiding her life-threatening sun ...

Lundbeck to present phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease at the 2026 AD/PD conference: Valby, Denmark Tuesday, ...

CLEVELAND, Ohio — Terminally ill Ohioans who want to decide when life should end have few options, with just two states on ...

A clinical-stage biotechnology company developing small-molecule therapies targeting amyloid beta (Aβ) for neurodegenerative ...

Brain lesions in Down syndrome aren’t always permanent. The vascular changes can fluctuate or even decrease over time as ...

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down ...

Researchers found that white matter lesions linked to Alzheimer’s do not always worsen, but can shrink during disease ...

The study analyzed the evolution of white matter hyperintensities (WMH), lesions typically associated with cerebral vascular ...